Literature DB >> 10218663

Metalloporphyrins are potent inhibitors of lipid peroxidation.

B J Day1, I Batinic-Haberle, J D Crapo.   

Abstract

The objectives of these studies were to determine whether metalloporphyrins could inhibit lipid peroxidation, characterize factors that influence their potency and compare their potency to prototypical antioxidants. Lipid peroxidation was initiated with iron and ascorbate in rat brain homogenates and the formation of thiobarbituric acid reactive species was used as an index of lipid peroxidation. Metalloporphyrins were found to be a novel and potent class of lipid peroxidation inhibitors. Inhibition of lipid peroxidation by metalloporphyrins was dependent on the transition metal ligated to the porphyrin, indicating that metal centered redox chemistry was important to the mechanism of their antioxidant activities. Manganese porphyrins with the highest superoxide dismutase (SOD) activities, MnOBTM-4-PyP and MnTM-2-PyP (charges are omitted throughout text for clarity), were the most potent inhibitors of lipid peroxidation with calculated IC50s of 1.3 and 1.0 microM, respectively. These manganese porphyrins were 2 orders of magnitude more potent than either trolox (IC50 = 204 microM) or rutin (IC50 = 112 microM). The potencies of the manganese porphyrins were related not only to their redox potentials and SOD activities, but also to other factors that may contribute to their ability to act as electron acceptors. The broad array of antioxidant activities possessed by metalloporphyrins make them attractive therapeutic agents in disease states that involve the overproduction of reactive oxygen species.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10218663     DOI: 10.1016/s0891-5849(98)00261-5

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  49 in total

1.  Effect of chronic variate stress on thiobarbituric-acid reactive species and on total radical-trapping potential in distinct regions of rat brain.

Authors:  L P Manoli; G D Gamaro; P P Silveira; C Dalmaz
Journal:  Neurochem Res       Date:  2000-07       Impact factor: 3.996

Review 2.  On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Dennis P Riley; Jay L Zweier; Christoph Thiemermann; Zhi-Qiang Wang; Daniela Salvemini
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

3.  Stability, disposition, and penetration of catalytic antioxidants Mn-porphyrin and Mn-salen and of methylprednisolone in spinal cord injury.

Authors:  Liqin Wu; Yichu Shan; Danxia Liu
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2012-06

4.  Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's disease.

Authors:  Li-Ping Liang; Jie Huang; Ruth Fulton; Jennifer N Pearson-Smith; Brian J Day; Manisha Patel
Journal:  Toxicol Appl Pharmacol       Date:  2017-04-08       Impact factor: 4.219

5.  Role of superoxide radical anion in the mechanism of apoB100 degradation induced by DHA in hepatic cells.

Authors:  Ursula Andreo; Josh Elkind; Courtney Blachford; Arthur I Cederbaum; Edward A Fisher
Journal:  FASEB J       Date:  2011-07-14       Impact factor: 5.191

6.  Manganese(III) tetrakis(1-methyl-4-pyridyl) porphyrin, a superoxide dismutase mimetic, reduces disease severity in in vitro and in vivo models for dry-eye disease.

Authors:  Agnė Žiniauskaitė; Symantas Ragauskas; Anita K Ghosh; Rubina Thapa; Anne E Roessler; Peter Koulen; Giedrius Kalesnykas; Jenni J Hakkarainen; Simon Kaja
Journal:  Ocul Surf       Date:  2019-02-23       Impact factor: 5.033

Review 7.  Antioxidants as potential therapeutics for lung fibrosis.

Authors:  Brian J Day
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

8.  Activation of mitogen-activated protein kinases by lysophosphatidylcholine-induced mitochondrial reactive oxygen species generation in endothelial cells.

Authors:  Nobuo Watanabe; Jaroslaw W Zmijewski; Wakako Takabe; Makiko Umezu-Goto; Claire Le Goffe; Azusa Sekine; Aimee Landar; Akira Watanabe; Junken Aoki; Hiroyuki Arai; Tatsuhiko Kodama; Michael P Murphy; Raman Kalyanaraman; Victor M Darley-Usmar; Noriko Noguchi
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

9.  Catalytic antioxidant AEOL 10150 treatment ameliorates sulfur mustard analog 2-chloroethyl ethyl sulfide-associated cutaneous toxic effects.

Authors:  Neera Tewari-Singh; Swetha Inturi; Anil K Jain; Chapla Agarwal; David J Orlicky; Carl W White; Rajesh Agarwal; Brian J Day
Journal:  Free Radic Biol Med       Date:  2014-05-09       Impact factor: 7.376

10.  Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors.

Authors:  Angela M Floden; Shanshan Li; Colin K Combs
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.